HealthEquity (HQY) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
28 May, 2026Executive summary
Net income rose 29% year-over-year to $69.4 million, with Adjusted EBITDA up 17% to $164.5 million and margin expanding to 46% from 42% last year.
Revenue grew 7% year-over-year to $354.6 million, driven by increases in service, custodial, and interchange revenue.
Total HSA assets climbed 19% to $37.1 billion, with 172,000 new HSAs added and HSA accounts up 8% to 10.6 million.
Accelerated digital engagement, with mobile monthly active usage up 90% year-over-year and two-thirds of Marketplace transactions via mobile app.
AI and automation drove significant operational efficiencies, reducing manual service efforts and fraud costs by nearly 90% year-over-year.
Financial highlights
Service revenue was $122.9 million (up 3%), custodial revenue $174.3 million (up 11%), and interchange revenue $57.4 million (up 5%).
Gross profit hit a record $256.3 million (72% of revenue, up from 68% last year).
GAAP net income was $69.4 million ($0.82/diluted share); non-GAAP net income $105.1 million ($1.24/diluted share).
Operating cash flow was $97.5 million, up from $64.7 million year-over-year; quarter-end cash balance $265.4 million.
$123 million returned to shareholders via stock repurchases during the quarter; board increased repurchase authorization by $1 billion.
Outlook and guidance
Fiscal 2027 revenue expected between $1.41 billion and $1.42 billion.
GAAP net income forecasted at $242–$248 million ($2.88–$2.95/share); non-GAAP net income $392–$398 million ($4.66–$4.73/share).
Adjusted EBITDA guidance raised to $625–$633 million.
Average yield on HSA cash projected at ~3.85% for FY27, with forward treasury contracts reducing yield volatility.
Guidance includes expanded share repurchase and potential debt reduction.
Latest events from HealthEquity
- Board recommends all proposals amid strong financials and enhanced governance and ESG oversight.HQY
Proxy filing13 May 2026 - Key votes include board elections, auditor ratification, and approval of compensation and equity plans.HQY
Proxy filing13 May 2026 - Record HSA and revenue growth, margin expansion, and raised guidance signal strong momentum.HQY
Q4 202617 Mar 2026 - Q1 saw double-digit growth, record HSA assets, and upgraded full-year guidance after a major acquisition.HQY
Q1 202531 Jan 2026 - Revenue up 23%, net income up 239%, and $300M buyback announced for Q2 FY25.HQY
Q2 202522 Jan 2026 - CEO transition to Scott Cutler set for January 2025, with strong growth and innovation focus.HQY
Investor Update14 Jan 2026 - Digital innovation, AI, and margin expansion fuel strong HSA growth and robust financial outlook.HQY
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Revenue up 21% with record HSA asset growth, strong guidance, and expanding market potential.HQY
Q3 202511 Jan 2026 - Record HSA growth, tech innovation, and legislative momentum fuel continued market leadership.HQY
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026